Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840015 · ClinicalTrials.gov registry record · NA
Use of Airpod Pros as Assistive Technology
A NA study of Hearing Aids and Hearing Loss, Adult-Onset, sponsored by The University of Texas at Dallas.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06840015: Recruiting NA study of Hearing Aids and Hearing Loss, Adult-Onset, sponsored by The University of Texas at Dallas.
NCT06840015 is a NA study of Hearing Aids and Hearing Loss, Adult-Onset that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 24 participants, below the 254-participant average among 4 other Hearing Aids trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06840015, a NA study of Hearing Aids and Hearing Loss, Adult-Onset, is actively recruiting participants, sponsored by The University of Texas at Dallas.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to investigate the suitability and effectiveness of the AirPod Pro 2nd and 3rd generation (AP) as hearing assistive technology for individuals with mild-to-moderate hearing loss when listening in noisy environments. Researchers will compare four types of assistive technology: hearing aids (HAs), AP, dedicated wireless remote microphones, and Smartphone wireless remote microphone. The main questions it aims to answer are: * Which assistive technology provides the greatest benefit for speech recognition in noisy environments? * How do these devices impact listening effort, as measured by reaction time in a dual-task activity and changes in pupil size? * What are participants' preferences for each device based on how easy it is to understand speech and their overall satisfaction? Participants will visit the lab for a single 3-hour session. They will listen to sentences using each device and repeat what they hear. During this task, their reaction times for the secondary task and changes in pupil size will be measured.
Primary Outcome
Speech recognition threshold (SRT) at 70.7% is the noise level at which a person can correctly repeat 70.7% of sentences. Determine the appropriate dB SNR to measure sentence recognition with assistive technologies. It is measured in decibels (dB). Lower values indicate better performance.
Conditions Studied
Interventions
- DEVICE Airpod Pro as hearing assistive technology
Study Locations (1)
Texas
- Callier Center for Communication Disorders - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06840015 shows while recruiting
NCT06840015 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 254-participant average among 4 other Hearing Aids trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Hearing Aids appearing as the primary indexed condition, and to 1 intervention - of which Airpod Pro as hearing assistive technology is the first listed.
NCT06840015 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06840015 about?
NCT06840015 is a clinical study titled "Use of Airpod Pros as Assistive Technology". The goal of this study is to investigate the suitability and effectiveness of the AirPod Pro 2nd and 3rd generation (AP) as hearing assistive technology for individuals with mild-to-moderate hearing loss when listening in noisy environments. Researchers will compare four types of assistive technolog...
What is the current status of trial NCT06840015?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-07-01. Estimated completion is 2026-07.
What conditions does trial NCT06840015 study?
This clinical trial studies the following conditions: Hearing Aids, Hearing Loss, Adult-Onset.
What interventions are being tested in trial NCT06840015?
The interventions under investigation include: Airpod Pro as hearing assistive technology (DEVICE).
Who is sponsoring clinical trial NCT06840015?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06840015 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Aids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Understanding Aided Speech Perception in Noise
RECRUITING · NA
-
Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing in the Normal Range
RECRUITING · NA
-
P-CHAT: Comparison of Direct to Consumer Delivery Models for Hearing Devices
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI